Nihal Sinha

Nihal Sinha is a Partner at F-Prime Capital based in London, United Kingdom, where he focuses on early-stage biotechnology and life sciences investments across Europe and the United States. Before joining the venture capital firm in 2013, he worked as a strategy consultant at BCG and served as an academic physician at Oxford University and UCL Hospitals. He earned an MB BChir with distinction from the University of Cambridge and is a Member of the Royal College of Physicians. As an investor and company builder, Sinha was part of the founding team at Orchard Therapeutics and has backed multiple therapeutics startups, including Charm Therapeutics, Ensoma, Curie Bio, and Caribou. His current investment focus primarily centers on advancing novel treatments in cell and gene therapy, alongside broader life sciences therapeutics targeting complex disease areas such as fibrosis.